TY  - JOUR
AU  - Jiménez-Guerrero, Rocío
AU  - Gasca, Jessica
AU  - Flores, M Luz
AU  - Pérez-Valderrama, Begoña
AU  - Tejera-Parrado, Cristina
AU  - Medina, Rafael
AU  - Tortolero, María
AU  - Romero, Francisco
AU  - Japón, Miguel A
AU  - Sáez, Carmen
PY  - 2018
DO  - 10.3390/cancers10120490
SN  - 2072-6694
UR  - http://hdl.handle.net/10668/13326
T2  - Cancers
AB  - Paclitaxel is a treatment option for advanced or metastatic bladder cancer after the failure of first-line cisplatin and gemcitabine, although resistance limits its clinical benefits. Mcl-1 is an anti-apoptotic protein that promotes resistance to...
LA  - en
KW  - apoptosis
KW  - autophagy
KW  - bladder cancer
KW  - obatoclax
KW  - paclitaxel
TI  - Obatoclax and Paclitaxel Synergistically Induce Apoptosis and Overcome Paclitaxel Resistance in Urothelial Cancer Cells.
TY  - research article
VL  - 10
ER  -